GlobeNewsWire
08 Jul 2026, 18:43 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
GRAIL's NHS-Galleri Trial failed to achieve its primary endpoint regarding the reduction of late-stage cancer diagnoses. — Failure of a primary clinical trial for a core product typically leads to massive valuation loss and severely impairs the company's commercial viability.
-0.90GRAIL's market capitalization decreased by over $2.2 billion, with shares dropping over 50% following the trial results. — Immediate and significant destruction of shareholder value indicates a severe negative market reaction.
-0.70GRAIL is facing a securities class action lawsuit alleging it misled investors about the trial's design and likelihood of success. — Legal liabilities and allegations of executive fraud create additional financial risk and reputational damage beyond the trial failure.
-0.40Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
The company faces a securities class action lawsuit following a trial failure and a massive loss in market capitalization.
The company is mentioned in the context of a stock plunge due to allegedly misleading financial statements.
The company is mentioned in the context of a stock plunge due to allegedly misleading financial statements.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
3h ago
